Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
10 Dividend Growth Stocks - June 2023
09:15am, Friday, 23'rd Jun 2023
This monthly series ranks a selection of dividend growth stocks in Dividend Radar and presents the ten top-ranked stocks for consideration and possible investment. The stocks were selected based on qu
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
03:37pm, Thursday, 22'nd Jun 2023
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
Daily Dividend Report: Corning, Starbucks, Lockheed Martin, Kroger, Pfizer
03:08pm, Thursday, 22'nd Jun 2023
Daily Dividend Report: Corning, Starbucks, Lockheed Martin, Kroger, Pfizer. Corning's Board of Directors today declared a quarterly dividend of $0.28 per share
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
02:06pm, Thursday, 22'nd Jun 2023
The CDC analysis suggests the shots will reduce the burden of RSV on hospitals in the fall.
I'm Buying These 3 Resilient Stocks During a Bear Market
10:23am, Thursday, 22'nd Jun 2023
Pfizer and Bristol Myers Squibb are pharmaceutical giants that are priced just right. NNN is a real estate investment trust that's increased its dividend for 33 straight years.
Is Pfizer Stock a Buy Now?
09:30am, Thursday, 22'nd Jun 2023
The market is punishing Pfizer's shares as the company's coronavirus-related tailwind evaporates. But the giant drugmaker is rapidly replenishing its lineup of medicines with brand-new products.
GSK and Pfizer RSV jab gets US CDC backing
03:31am, Thursday, 22'nd Jun 2023
GSK PLC (LSE:GSK, NYSE:GSK) received a second dose of good this week that augers well for the roll-out of its respiratory syncytial virus (RSV) jab. An advisory committee to the US Centers for Diseas
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
05:57pm, Wednesday, 21'st Jun 2023
The CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
FDA Expands Pfizer's (PFE) Talzenna Label in Prostate Cancer
03:34pm, Wednesday, 21'st Jun 2023
Following FDA's label-expansion approval, Pfizer's (PFE) Talzenna is the first PARP inhibitor approved in combination with existing standard of care for treating HRR gene-mutated mCRPC.
Buy Right, Sell Right: 2 Top Dividend Buys From Our Top 10 List
10:49am, Wednesday, 21'st Jun 2023
While there are many good quality undervalued stocks, it's clear that some are best in class. I decided to share our picks with the SA community. Here are two of our favorite dividend stocks in the cu
Earn A Dividend Check Every Month With These 3 Stocks
10:46am, Wednesday, 21'st Jun 2023
This article discusses three high-quality blue-chip dividend stocks that can provide investors with monthly dividend income when staggered. These stocks are currently trading at reasonable valuations
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
08:35am, Wednesday, 21'st Jun 2023
Pfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the shot should be administered in the U.S.
US CDC advisers weigh use of GSK, Pfizer RSV vaccines in older adults
06:07am, Wednesday, 21'st Jun 2023
A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday will vote on whether to recommend the use of recently approved vaccines from Pfizer and GSK to prevent sev
GSK: Does new RSV jab have the edge of Pfizer's vaccine?
03:13am, Wednesday, 21'st Jun 2023
GSK PLC (LSE:GSK, NYSE:GSK)'s respiratory syncytial virus (RSV) vaccine, Arexvy, demonstrated robust long-term protection in a late-stage trial, targeting older adults, the pharma giant revealed on We
Most Ukrainian businesses are fully operational, says Kyiv-based American Chamber of Commerce
03:50pm, Tuesday, 20'th Jun 2023
More than 480 days after Russia launched its invasion of Ukraine, 84% of the companies surveyed by the American Chamber of Commerce in Ukraine are fully operational.
